v3.22.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows used in operating activities:    
Net loss $ (6,635,187) $ (5,626,925)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 98,363 28,775
Stock based compensation 522,234 629,207
Accretion of right-of-use lease asset 9,717 (1,723)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (342,641) 153,775
Accounts receivable 17,116 91,880
Deposits (21,146)
Accounts payable and other current liabilities (443,239) 278,663
Deferred revenue 114,849 (100,000)
Due to related parties 11,855 20,039
Net cash used in operating activities (6,668,079) (4,526,309)
Cash flows used in investing activities:    
Purchases of property and equipment (136,795) (54,630)
Net cash used in investing activities (136,795) (54,630)
Cash flows provided by financing activities:    
Proceeds from the issuance of common stock, net 17,456,092 7,260,869
Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units and net stock option expense (77,477) (106,391)
Net cash provided by financing activities 17,378,615 7,154,478
Net increase in cash and restricted cash 10,573,741 2,573,539
Cash and restricted cash at beginning of period 9,908,301 9,604,780
Cash and restricted cash at end of period 20,482,042 12,178,319
Supplemental disclosures of non-cash investing and financing activities:    
Issuance of common stock under cashless warrant exercises 676 0
Par value of shares issued for vested restricted stock units and net stock option exercise 33 71
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets:    
Cash and cash equivalents 20,394,536 12,131,593
Restricted cash 87,506 46,726
Cash and restricted cash $ 20,482,042 $ 12,178,319

Source